Ultragenyx moves CFO start date to Oct 9 from Oct 16, 2023

Ultragenyx Pharmaceutical Inc.

Howard Horn's appointment as CFO & EVP, Corporate Strategy effective October 9, 2023, one week earlier than originally announced.
Amendment No. 1 to offer letter dated September 6, 2023 changes only the start date; all other terms unchanged.
Original effective date of October 16, 2023 was disclosed in the July 12, 2023 Form 8-K.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Howard Horn

Chief Financial Officer and Executive Vice President, Corporate Strategy

RARE · Ultragenyx Pharmaceutical Inc.

Effective: 2023-10-09
Filed: September 8, 2023, 7:59 PM ET

Mr. Horn and the Company have modified the effective date of Mr. Horn’s appointment as the Company’s CFO and EVP, Corporate Strategy from October 16, 2023 to October 9, 2023 (the “Effective Date”).

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Howard Horn was appointed as Chief Financial Officer and Executive Vice President, Corporate Strategy at Ultragenyx Pharmaceutical Inc..

Action: appointed
Role: Chief Financial Officer and Executive Vice President, Corporate Strategy

Exact text from the filing

Mr. Horn and the Company have modified the effective date of Mr. Horn’s appointment as the Company’s CFO and EVP, Corporate Strategy from October 16, 2023 to October 9, 2023 (the “Effective Date”).

View on SEC.gov

Ultragenyx Pharmaceutical Inc. filing history →

Source: SEC EDGAR

accession 0000950170-23-047138

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.